BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23155239)

  • 1. An immobilized antibody targeting N-cadherin facilitates spread of N-cadherin-positive tumour cells.
    Maes D; Bracke M; Ost P
    Anticancer Res; 2012 Nov; 32(11):4755-7. PubMed ID: 23155239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma.
    Van Marck V; Stove C; Van Den Bossche K; Stove V; Paredes J; Vander Haeghen Y; Bracke M
    Cancer Res; 2005 Oct; 65(19):8774-83. PubMed ID: 16204047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude mice.
    Jacobs K; Feys L; Vanhoecke B; Van Marck V; Bracke M
    Eur J Cancer Prev; 2011 May; 20(3):207-16. PubMed ID: 21445019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.
    Laidler P; Gil D; Pituch-Noworolska A; Ciołczyk D; Ksiazek D; Przybyło M; Lityńska A
    Acta Biochim Pol; 2000; 47(4):1159-70. PubMed ID: 11996105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-cadherin expression reduces invasion of malignant melanoma.
    Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
    Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
    Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C
    Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody recognition of peptide sequences from the cell-cell adhesion proteins: N- and E-cadherins.
    Lutz KL; Szabo LA; Thompson DL; Siahaan TJ
    Pept Res; 1996; 9(5):233-9. PubMed ID: 9000249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural cell-cell and cell-substrate adhesion through N-cadherin, N-CAM and L1.
    Wiertz RW; Marani E; Rutten WL
    J Neural Eng; 2011 Aug; 8(4):046004. PubMed ID: 21628769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate moieties of N-cadherin from human melanoma cell lines.
    Ciołczyk-Wierzbicka D; Gil D; Hoja-Łukowicz D; Lityńska A; Laidler P
    Acta Biochim Pol; 2002; 49(4):991-8. PubMed ID: 12545205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
    Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
    Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of pig granulosa cell adhesion and growth in vitro by immunoneutralization of epithelial cadherin.
    ; ; . PubMed ID: 11058443
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.